IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RENAE H KLEE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1609981125
CMS profile
665404
Location
SACRAMENTO, CA

General Payments · PY2021–2024

$4,426.81

  • Reported across 160 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,638.09

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nurse Practitioner CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,633.54 52
Education $4.55 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $529.53 13
Teva Pharmaceuticals USA, Inc. $343.09 9
Alkermes, Inc. $201.92 7
ITI, Inc. $154.01 7
ABBVIE INC. $107.30 4
Otsuka America Pharmaceutical, Inc. $86.37 4
Indivior Inc. $73.10 3
Neurocrine BioSciences, Inc. $63.64 3
E.R. Squibb & Sons, L.L.C. $54.46 2
Vanda Pharmaceuticals Inc. $24.67 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $486.08 10
PY2022 $861.54 49
PY2023 $1,441.10 48
PY2024 $1,638.09 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $27.66 08/09/2024 Food and Beverage Undisputed 01/23/2026 1104083720 CMS
ABBVIE INC. $32.59 09/23/2024 Food and Beverage Undisputed 01/23/2026 1104083722 CMS
ABBVIE INC. $17.99 10/21/2024 Food and Beverage Undisputed 01/23/2026 1104083724 CMS
ABBVIE INC. $29.06 12/10/2024 Food and Beverage Undisputed 01/23/2026 1104083726 CMS
Alkermes, Inc. $22.69 01/16/2024 Food and Beverage Undisputed 01/23/2026 1120532791 CMS
Alkermes, Inc. $23.31 03/14/2024 Food and Beverage Undisputed 01/23/2026 1120532795 CMS
Alkermes, Inc. $27.88 09/06/2024 Food and Beverage Undisputed 01/23/2026 1120532799 CMS
Alkermes, Inc. $32.33 10/10/2024 Food and Beverage Undisputed 01/23/2026 1120532803 CMS
Alkermes, Inc. $33.95 10/22/2024 Food and Beverage Undisputed 01/23/2026 1120532807 CMS
Alkermes, Inc. $30.71 12/16/2024 Food and Beverage Undisputed 01/23/2026 1120532812 CMS
Alkermes, Inc. $31.05 12/19/2024 Food and Beverage Undisputed 01/23/2026 1120532816 CMS
E.R. Squibb & Sons, L.L.C. $25.75 10/25/2024 Food and Beverage Undisputed 01/23/2026 1101411061 CMS
E.R. Squibb & Sons, L.L.C. $28.71 11/19/2024 Food and Beverage Undisputed 01/23/2026 1101411085 CMS
Indivior Inc. $19.17 02/23/2024 Food and Beverage Undisputed 01/23/2026 1144558919 CMS
Indivior Inc. $24.78 03/26/2024 Food and Beverage Undisputed 01/23/2026 1144558921 CMS
Indivior Inc. $29.15 04/23/2024 Food and Beverage Undisputed 01/23/2026 1144558923 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.49 01/13/2024 Food and Beverage Undisputed 01/23/2026 1143526626 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.82 02/27/2024 Food and Beverage Undisputed 01/23/2026 1143526628 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.72 03/08/2024 Food and Beverage Undisputed 01/23/2026 1143526630 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.43 04/23/2024 Food and Beverage Undisputed 01/23/2026 1143526632 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.77 08/22/2024 Food and Beverage Undisputed 01/23/2026 1143526634 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.73 11/02/2024 Food and Beverage Undisputed 01/23/2026 1143526636 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.05 12/04/2024 Food and Beverage Undisputed 01/23/2026 1143526638 CMS
Janssen Pharmaceuticals, Inc $27.88 01/19/2024 Food and Beverage Undisputed 01/23/2026 1077937204 CMS
Janssen Pharmaceuticals, Inc $125.00 01/31/2024 Food and Beverage Undisputed 01/23/2026 1077937238 CMS
Janssen Pharmaceuticals, Inc $33.94 02/22/2024 Food and Beverage Undisputed 01/23/2026 1077937158 CMS
Janssen Pharmaceuticals, Inc $16.57 03/07/2024 Food and Beverage Undisputed 01/23/2026 1077937200 CMS
Janssen Pharmaceuticals, Inc $26.67 03/20/2024 Food and Beverage Undisputed 01/23/2026 1077937396 CMS
Janssen Pharmaceuticals, Inc $4.55 03/28/2024 Education Undisputed 01/23/2026 1077937586 CMS
Janssen Pharmaceuticals, Inc $9.56 08/12/2024 Food and Beverage Undisputed 01/23/2026 1077938076 CMS
Janssen Pharmaceuticals, Inc $50.00 08/25/2024 Food and Beverage Undisputed 01/23/2026 1077938242 CMS
Janssen Pharmaceuticals, Inc $35.43 09/26/2024 Food and Beverage Undisputed 01/23/2026 1077937338 CMS
Janssen Pharmaceuticals, Inc $121.47 09/26/2024 Food and Beverage Undisputed 01/23/2026 1077937848 CMS
Janssen Pharmaceuticals, Inc $28.81 10/30/2024 Food and Beverage Undisputed 01/23/2026 1077937156 CMS
Janssen Pharmaceuticals, Inc $11.84 12/02/2024 Food and Beverage Undisputed 01/23/2026 1077937448 CMS
Janssen Pharmaceuticals, Inc $37.81 12/06/2024 Food and Beverage Undisputed 01/23/2026 1077937208 CMS
Neurocrine Biosciences, Inc. $21.54 03/01/2024 Food and Beverage Undisputed 01/23/2026 1150972151 CMS
Neurocrine Biosciences, Inc. $22.79 08/22/2024 Food and Beverage Undisputed 01/23/2026 1150964995 CMS
Neurocrine Biosciences, Inc. $19.31 10/17/2024 Food and Beverage Undisputed 01/23/2026 1150983279 CMS
Otsuka America Pharmaceutical, Inc. $25.31 08/21/2024 Food and Beverage Undisputed 01/23/2026 1119113565 CMS
Otsuka America Pharmaceutical, Inc. $16.59 09/20/2024 Food and Beverage Undisputed 01/23/2026 1119113567 CMS
Otsuka America Pharmaceutical, Inc. $26.71 09/30/2024 Food and Beverage Undisputed 01/23/2026 1119113569 CMS
Otsuka America Pharmaceutical, Inc. $17.76 11/15/2024 Food and Beverage Undisputed 01/23/2026 1119113571 CMS
Teva Pharmaceuticals USA, Inc. $1.03 01/31/2024 Food and Beverage Undisputed 01/23/2026 1151709285 CMS
Teva Pharmaceuticals USA, Inc. $22.69 01/31/2024 Food and Beverage Undisputed 01/23/2026 1151709287 CMS
Teva Pharmaceuticals USA, Inc. $15.35 02/14/2024 Food and Beverage Undisputed 01/23/2026 1151709289 CMS
Teva Pharmaceuticals USA, Inc. $125.00 03/06/2024 Food and Beverage Undisputed 01/23/2026 1151709331 CMS
Teva Pharmaceuticals USA, Inc. $22.13 03/14/2024 Food and Beverage Undisputed 01/23/2026 1151709321 CMS
Teva Pharmaceuticals USA, Inc. $111.58 03/26/2024 Food and Beverage Undisputed 01/23/2026 1151709291 CMS
Teva Pharmaceuticals USA, Inc. $15.25 08/16/2024 Food and Beverage Undisputed 01/23/2026 1151709367 CMS
Teva Pharmaceuticals USA, Inc. $24.30 09/27/2024 Food and Beverage Undisputed 01/23/2026 1151709377 CMS
Teva Pharmaceuticals USA, Inc. $5.76 12/12/2024 Food and Beverage Undisputed 01/23/2026 1151709387 CMS
Vanda Pharmaceuticals Inc. $24.67 10/11/2024 Food and Beverage Undisputed 01/23/2026 1133952282 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.